Remove tag medicines-spending
article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

million price tag. But the justification for Roctavian’s cost will depend on positive responses to the treatment, says Dr. Guy Young, professor of pediatrics at University of Southern California’s Keck School of Medicine. The post Can gene therapies for haemophilia defend their high price tags? million ($1.8

FDA 111
article thumbnail

What states use Ozempic the most?

The Checkup by Singlecare

The #ozempic tag on TikTok has amassed over 1 billion views to date. Saving on this medication is important because research shows that spending on Ozempic has increased by 90% since 2020. Ozempic became one of the most talked about drugs in 2023. Elon Musk posted his endorsement of Ozempic on X. What does Ozempic do?

Insurance 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Brands spend a huge amount of time and effort building hyper-relevant content relationships with their customers.”. Jeremy Richter, Tag.

article thumbnail

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

pharmaphorum

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S. Oral therapy data presented at ASH.

article thumbnail

A history of Pfizer

pharmaphorum

After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr Pepper’s expansion in the 1880s. By 1868, Pfizer’s revenues had doubled since the start of the war, and their product lines had expanded greatly.

article thumbnail

Advanced therapies and the high-profile pricing dilemma

pharmaphorum

However, R&D efforts into biological medicine have moved into the ascendency in recent times, as the treatments often offer targeted therapy and better outcomes. The model for making a profit from medicine is geared towards delivering medicines regularly, usually for chronic conditions. However, with a price tag of €1.58

130
130